GRE-213

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameGRE-213
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGrespo AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrespo AB
Active IndicationsN/A
Inactive IndicationsNeurodegenerative Diseases

Other Information

ATC CodeN/A
Related LinksN/A